Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue

被引:61
作者
Hokynar, K
Brunstein, J
Söderlund-Venermo, M
Kiviluoto, O
Partio, EK
Konttinen, Y
Hedman, K
机构
[1] Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Mil Hosp, Helsinki, Finland
[3] Univ Helsinki, Dextra Med Ctr, Helsinki, Finland
[4] Univ Helsinki, Dept Anat, Helsinki, Finland
[5] Univ Helsinki, Dept Oral Med, Helsinki, Finland
[6] Univ Helsinki, Dept Rheumatol, Helsinki, Finland
关键词
D O I
10.1099/0022-1317-81-4-1017
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Primary infection by human parvovirus B19 is often accompanied by arthropathy of varying duration, of which the most severe cases can be indistinguishable from rheumatoid arthritis (RA), While this might seem to imply a role in PA pathogenesis, recent studies have verified long-term persistence of B19 DNA in synovial tissue not only in patients with rheumatoid or juvenile arthritis, but also in immunocompetent, non-arthritic individuals with a history of prior B19 infection. However, the latter data are based on PCR amplification of short segments of DNA, with little sequence information. We determined the nucleotide sequence and examined the integrity of the protein-coding regions of B19 genomes persisting in synovial tissue and compared the results with data from synovial tissues of recently infected patients. In synovium of both previously and recently infected subjects, the viral coding regions were found to be present in an apparently continuous, intact DNA molecule. Comparison with sequences reported from blood or bone marrow showed that the synoviotropism or persistence of the B19 virus DNA was not due to exceptional mutations or particular genotype variants. The synovial retention of full-length viral genomes may represent a physiological process functioning in long-term storage of foreign macromolecules in this tissue.
引用
收藏
页码:1017 / 1025
页数:9
相关论文
共 56 条
[1]   DETECTION OF ANTIBODIES AND ANTIGENS OF HUMAN PARVOVIRUS B19 BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
ANDERSON, LJ ;
TSOU, C ;
PARKER, RA ;
CHORBA, TL ;
WULFF, H ;
TATTERSALL, P ;
MORTIMER, PP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (04) :522-526
[2]   OCCURRENCE OF INFECTION WITH A PARVOVIRUS-LIKE AGENT IN CHILDREN WITH SICKLE-CELL-ANEMIA DURING A 2-YEAR PERIOD [J].
ANDERSON, MJ ;
DAVIS, LR ;
HODGSON, J ;
JONES, SE ;
MURTAZA, L ;
PATTISON, JR ;
STROUD, CE ;
WHITE, JM .
JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (07) :744-749
[3]   AN OUTBREAK OF ERYTHEMA INFECTIOSUM ASSOCIATED WITH HUMAN PARVOVIRUS INFECTION [J].
ANDERSON, MJ ;
LEWIS, E ;
KIDD, IM ;
HALL, SM ;
COHEN, BJ .
JOURNAL OF HYGIENE, 1984, 93 (01) :85-93
[4]   SEQUENCE OF THE RIGHT HAND TERMINAL PALINDROME OF THE HUMAN B19 PARVOVIRUS GENOME HAS THE POTENTIAL TO FORM A STEM PLUS ARMS STRUCTURE [J].
ASTELL, CR ;
BLUNDELL, MC .
NUCLEIC ACIDS RESEARCH, 1989, 17 (14) :5857-5857
[5]   2 AMINO-ACID SUBSTITUTIONS WITHIN THE CAPSID ARE COORDINATELY REQUIRED FOR ACQUISITION OF FIBROTROPISM BY THE LYMPHOTROPIC STRAIN OF MINUTE VIRUS OF MICE [J].
BALLGOODRICH, LJ ;
TATTERSALL, P .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3415-3423
[6]   ELECTRON MICROSCOPY OF HUMAN SYNOVIAL MEMBRANE [J].
BARLAND, P ;
NOVIKOFF, AB ;
HAMERMAN, D .
JOURNAL OF CELL BIOLOGY, 1962, 14 (02) :207-+
[7]   INVITRO IDENTIFICATION OF A B19 PARVOVIRUS PROMOTER [J].
BLUNDELL, MC ;
BEARD, C ;
ASTELL, CR .
VIROLOGY, 1987, 157 (02) :534-538
[8]   ERYTHROCYTE-P ANTIGEN - CELLULAR RECEPTOR FOR B19 PARVOVIRUS [J].
BROWN, KE ;
ANDERSON, SM ;
YOUNG, NS .
SCIENCE, 1993, 262 (5130) :114-117
[9]  
BROWN T, 1984, LANCET, V2, P1033
[10]   IDENTIFICATION OF 3 MAJOR SYNOVIAL LINING CELL-POPULATIONS BY MONOCLONAL-ANTIBODIES DIRECTED TO IA ANTIGENS AND ANTIGENS ASSOCIATED WITH MONOCYTES MACROPHAGES AND FIBROBLASTS [J].
BURMESTER, GR ;
DIMITRIUBONA, A ;
WATERS, SJ ;
WINCHESTER, RJ .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1983, 17 (01) :69-82